Compare Globus Medical Inc. Class A Common Stock (GMED) vs Simon Property Group Inc (SPG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Simon Property Group Inc — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Simon Property Group Inc trades at $200.57 (market cap $64.29B). The key difference: Simon Property Group Inc is far larger — about 6.3× Globus Medical Inc. Class A Common Stock's market cap, and Simon Property Group Inc pays a 4.48% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Simon Property Group Inc for 100 Days on average.
| GMED | SPG | |
|---|---|---|
Market Cap | $10.25B | $64.29B |
Volume | 1,059,528 | 1,236,199 |
Sector | Health | Real Estate |
52-Week High | $96.82 | $236.70 |
52-Week Low | $58.33 | $173.35 |
Typical Hold Time | 0 Days | 100 Days |
Enterprise Value | $9.76B | $92.74B |
Dividend Yield | — | 4.48% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Simon Property Group (SPG) trades at $200.65, down 0.38% with bearish technical signals. The REIT shows strong fundamentals with 2025 revenue of $6.36B, net income of $4.63B (72.7% margin), and attractive valuation at 14.16 P/E. Recent earnings show mixed results with Q2 2026 missing expectations. The company maintains strong leasing demand and recently launched Simon Media Network to monetize mall traffic.
SPG offers value with solid dividend yield and double-digit return potential, though faces headwinds from rising bond yields and $2B debt maturities in 2024. Analyst consensus at $218.45 target suggests 8.9% upside, supported by accelerating NOI growth and A-rated balance sheet strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Simon Property Group Inc
Simon Property Group is the second- largest real estate investment trust in the United States. Its portfolio includes an interest in 207 properties: 119 traditional malls, 69 premium outlets, 14 Mills centers (a combination of a traditional mall, outlet center, and big-box retailers), six lifestyle centers, and five other retail properties. Simon's portfolio averaged $693 in sales per square foot over the 12 months prior to the pandemic. The company also owns a 21% interest in Klepierre, a European retail company with investments in shopping centers in 16 countries, and joint venture interests in 33 premium outlets across 11 countries.
Read more on SPG →
